Theracap

Theracap (Sodium Iodide (131I)) is a radioactive iodine therapy used for thyroid conditions. This oral capsule helps manage hyperthyroidism and thyroid cancer by reducing hormone production. Suitable for patients requiring targeted radiation treatment. Short-term use only under medical supervision.

Theracap is primarily used to treat overactive thyroid (hyperthyroidism) and certain types of thyroid cancer. It works by selectively targeting thyroid cells to reduce hormone production or destroy cancerous tissue. Patients often ask, 'what is Sodium Iodide (131I) used for' when exploring treatment options for thyroid-related disorders.

After taking Theracap, some patients may experience mild nausea or fatigue as the body adjusts to the treatment. Dry mouth or changes in taste are also reported but typically resolve over time. Most effects are temporary and linked to the body’s response to radiation.

Theracap should be handled with care due to its radioactivity; avoid close contact with others for several days post-treatment. Pregnant individuals or those breastfeeding must not use this medication. Follow local guidelines for disposal and safety measures to minimize exposure risks.

Certain medications, such as thyroid hormones or lithium, may interfere with Theracap’s effectiveness. Avoid iodine-rich foods or supplements during treatment unless directed otherwise. Consult a healthcare provider before combining with other drugs to prevent unintended interactions.